# A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703)

> **NCT00725491** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 259 (actual)

## Conditions studied

- Controlled Ovarian Stimulation

## Interventions

- **DRUG:** ganirelix
- **DRUG:** triptorelin

## Key facts

- **NCT ID:** NCT00725491
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 259 (ACTUAL)
- **Last updated:** 2022-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00725491

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00725491, "A Study to Assess the Efficacy and Safety of Ganirelix (Orgalutran®) Treatment in Chinese Women Undergoing Controlled Ovarian Stimulation for in Vitro Fertilization (IVF) or Intra Cytoplasmatic Sperm Injection (ICSI) (Study 38651)(P05703)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00725491. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*